HomeSEEL • NASDAQ
add
Seelos Therapeutics Inc
Previous close
$0.30
Day range
$0.28 - $0.30
Year range
$0.28 - $49.85
Market cap
3.92M USD
Avg Volume
510.02K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 653.00K | — |
Operating expense | -21.45M | 46.85% |
Net income | -5.45M | 70.77% |
Net profit margin | -835.07 | — |
Earnings per share | -7.47 | -46.47% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 3.00M | -80.71% |
Total assets | 5.42M | -76.18% |
Total liabilities | 38.93M | 16.70% |
Total equity | -33.51M | — |
Shares outstanding | 13.68M | — |
Price to book | -0.09 | — |
Return on assets | -344.23% | — |
Return on capital | 122.17% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -5.45M | 70.77% |
Cash from operations | -1.91M | 85.40% |
Cash from investing | — | — |
Cash from financing | 2.32M | 223.04% |
Net change in cash | 412.00K | 102.75% |
Free cash flow | 2.13M | 138.17% |
About
CEO
Founded
2016
Headquarters
Website
Employees
15